-
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01)
(PA-17-073)
National Institute on Aging
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34)
(PAR-17-068)
National Institute of General Medical Sciences
Application Receipt Date(s): May 24, 2017; May 24, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NCI Transition Career Development Award to Promote Diversity (K22)
(PAR-17-069)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Programs to Enhance Research Training (IPERT) (R25)
(PAR-17-070)
National Institute of General Medical Sciences
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): February 7, 2017; January 23, 2018; January 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Leveraging Electronic Health Records for Alcohol Services Research (R21/R33)
(PAR-17-071)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32)
(PAR-17-072)
National Institute on Aging
National Institute of Nursing Research
Application Receipt Date(s): March 2, 2017; January 25, 2018; and January 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32)
(RFA-AG-17-063)
National Institute on Aging
Application Receipt Date(s): February 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (R01)
(RFA-AI-16-082)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): March 28, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date .
-
Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research (U01)
(RFA-AI-16-083)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date .
-
Development of Multipurpose Prevention Technologies: A Strategy for the Prevention of Sexually Transmitted Infections (STIs) (R61/R33)
(RFA-AI-16-085)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): March 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date .
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Pilot Clinical Trials Targeting HIV-1 Reservoirs in Children (U01)
(RFA-AI-16-086)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): March 14 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
PDX Development and Trial Centers (PDTCs) (U54)
(RFA-CA-17-003)
National Cancer Institute
Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24)
(RFA-CA-17-004)
National Cancer Institute
Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Mechanisms of Cancer Drug Resistance and Sensitivity (U54)
(RFA-CA-17-009)
National Cancer Institute
Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
-
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
(RFA-CA-17-014)
National Cancer Institute
Application Receipt Date(s): February 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Optimizing the HIV Care Continuum for Substance Abusing Populations at High-Risk and/or Living with HIV (R01)
(RFA-DA-17-024)
National Institute on Drug Abuse
Application Receipt Date(s): May 9, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
(RFA-DK-16-505)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: Revision Application for the Human Islet Research Network Coordinating Center (U01)
(RFA-DK-17-501)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Research Centers in Minority Institutions (U54)
(RFA-MD-17-003)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Frontotemporal Degeneration FTD Sequencing Consortium: Discovery, replication and validation (UG3/UH3)
(RFA-NS-17-017)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): February 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.